Skip to main content
61°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about PTGX
Recent news which mentions PTGX
< Previous
1
2
3
4
Next >
Mid-Day Market Update: Nasdaq Down 400 Points; Arch Resources Shares Jump
April 26, 2022
Tickers
ARCH
CENN
EDN
KEN
Tags
TZOO
MX
NEXT
From
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
Tickers
ACON
AGRX
ARCH
AVDL
Tags
PII
JCSE
ARCH
From
Benzinga
Mid-Morning Market Update: Markets Open Lower; Dow Dips 300 Points
April 26, 2022
Tickers
AVDL
INDO
JCSE
MX
Tags
News
SKYH
Market News
From
Benzinga
Why Protagonist Therapeutics Shares Are Crashing Today
April 26, 2022
Tickers
PTGX
Tags
Briefs
Movers
why it's moving
From
Benzinga
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag
April 26, 2022
Tickers
AGRX
AMAM
BGNE
GILD
Tags
Movers
Health Care
Market News
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Tickers
AGRX
AVDL
BBLG
ERYP
Tags
UHS
MRKR
AVDL
From
Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
Tickers
AGRX
AIM
ALZN
AVDL
Tags
Pre/Market Outlook
News
AGRX
From
Benzinga
Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint
April 25, 2022
Tickers
PTGX
Tags
General
PTGX
Small Cap
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Tickers
BSGM
CLSN
ENDP
KTRA
Tags
PTGX
Movers
CLSN
From
Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Tickers
AIRG
AMST
APCX
AREB
Tags
CRXT
MXC
RERE
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Tickers
BFRI
CLRB
HSTO
ISO
Tags
HSTO
BFRI
BZI/TFM
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
April 14, 2022
Tickers
ABBV
AMRX
BNTX
BYSI
Tags
PFE
Penny Stocks
Small Cap
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 14, 2022
Tickers
AGRX
AIM
AIRG
APLD
Tags
LBPS
BFRI
CBAT
From
InvestorPlace
FDA Intends To Revoke Protagonist Therapeutics' Rusfertide Breakthrough Tag In Rare Form Of Blood Cancer
April 14, 2022
Tickers
PTGX
Tags
PTGX
General
Briefs
From
Benzinga
Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech
March 16, 2022
Tickers
JNJ
PTGX
Tags
Benzinga
JNJ
Small Cap
From
Benzinga
Protagonist Therapeutics's Return On Capital Employed Overview
March 03, 2022
Tickers
PTGX
Tags
PTGX
Market News
Earnings
From
Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Tickers
AGIO
BMY
HRMY
JNJ
Tags
NASDAQ:HRMY,NASDAQ:SDGR,NASDAQ:PTGX,NYSEARCA:XBI,NASDAQ:SNY,NYSE:BMY,NASDAQ:AGIO,NYSE:JNJ
JNJ
XBI
From
InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
ONCY
GBT
AGIO
From
Benzinga
Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate
December 03, 2021
Tickers
JNJ
PTGX
Tags
Trading Ideas
Benzinga
JNJ
From
Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
Tickers
BGNE
BMY
ESPR
IBB
Tags
XENE
General
PTGX
From
Benzinga
What 9 Analyst Ratings Have To Say About Protagonist Therapeutics
November 15, 2021
Tickers
PTGX
Tags
BZI/AAR
PTGX
Market News
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
GMAB
TCI
DRNA
From
Benzinga
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
November 08, 2021
Tickers
PTGX
Tags
PTGX
Recent Press Releases
Market News
From
Motley Fool
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List
November 01, 2021
Tickers
AMC
ASLE
BTBT
GLG
Tags
Short Sellers
Short Squeeze
Trading Ideas
From
Benzinga
Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop
October 25, 2021
Tickers
AGC
DBGI
PALT
PROG
Tags
PALT
AGC
PTGX
From
InvestorPlace
5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger
October 25, 2021
Tickers
AGC
AMC
DBGI
GME
Tags
Fintel
Benzinga
Short Squeeze
From
Benzinga
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Tickers
ADPT
ATHA
AVRO
IBB
Tags
News
RHHBY
MRK
From
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers
ABEO
ABT
AVDL
AVRO
Tags
JSPR
BFRI
Penny Stocks
From
Benzinga
Ten stocks worth watching next week
October 16, 2021
Tickers
AA
ADMP
FCEL
MFH
Tags
RSLS
PTGX
OEG
From
AC Investor Blog
What 10 Analyst Ratings Have To Say About Protagonist Therapeutics
October 13, 2021
Tickers
PTGX
Tags
BZI/AAR
PTGX
Benzinga
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.